Previous research has demonstrated that ETV4 can facilitate the development of HCC by activating several key oncogenes and related signaling pathways, including the MMP1, uPAR, and Wnt/β-cyclin pathways [38–41]. Here, ETV4 is linked to hepatocellular carcinoma.